Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-05-05

FDA Approved: BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Padagis US LLC)

View source ↗

Summary

The FDA approved a supplemental application for benazepril hydrochloride and hydrochlorothiazide (an antihypertensive combination) submitted by Padagis US LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Benazepril hydrochloride and hydrochlorothiazide (Benazepril hydrochloride and hydrochlorothiazide)

Snippet

SUPPL AP for BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE (BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE)